Roland LT, Smith TL, Schlosser RJ et al (2020) Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health-sponsored workshop. Int Forum Allergy Rhinol 10(9):1037–1042. https://doi.org/10.1002/alr.22633

Article  PubMed  Google Scholar 

Orlandi RR, Kingdom TT, Smith TL et al (2021) International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol 11(3):213–739. https://doi.org/10.1002/alr.22741

Article  PubMed  Google Scholar 

Fokkens WJ, Lund VJ, Hopkins C et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(S29):1–464. https://doi.org/10.4193/Rhin20.600

Article  PubMed  Google Scholar 

Fokkens WJ, Lund V, Bachert C et al (2019) EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy 74(12):2312–2319. https://doi.org/10.1111/all.13875

Article  PubMed  Google Scholar 

Thamboo A, Kilty S, Witterick I et al (2021) Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis. J Otolaryngol Head Neck Surg 50(1):15. https://doi.org/10.1186/s40463-021-00493-2

Article  PubMed  PubMed Central  Google Scholar 

Bachert C, Han JK, Desrosiers M et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394(10209):1638–1650. https://doi.org/10.1016/S0140-6736(19)31881-1

Article  CAS  PubMed  Google Scholar 

Gevaert P, Omachi TA, Corren J et al (2020) Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol 146(3):595–605. https://doi.org/10.1016/j.jaci.2020.05.032

Article  CAS  PubMed  Google Scholar 

Han JK, Bachert C, Fokkens W et al (2021) Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 9(10):1141–1153. https://doi.org/10.1016/S2213-2600(21)00097-7

Article  CAS  PubMed  Google Scholar 

Bachert C, Han JK, Desrosiers MY et al (2022) Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol 149(4):1309-1317.e12. https://doi.org/10.1016/j.jaci.2021.08.030

Article  CAS  PubMed  Google Scholar 

Biadsee A, Payne S, Sowerby LJ (2022) Can we make biologic therapy more affordable? Int Forum Allergy Rhinol. https://doi.org/10.1002/alr.23039

Article  PubMed  Google Scholar 

Swisher AR, Kshirsagar RS, Adappa ND, Liang J (2021) Dupilumab adverse events in nasal polyp treatment: analysis of FDA adverse event reporting system. Laryngoscope. https://doi.org/10.1002/lary.29992

Article  PubMed  Google Scholar 

Sharma A, Minh Duc NT, Luu Lam Thang T et al (2021) A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med 36(10):3179–3187. https://doi.org/10.1007/s11606-021-06737-1

Article  PubMed  PubMed Central  Google Scholar 

Liu M, Liu J, Weitzel EK, Chen PG (2022) The predictive utility of the 22-item sino-nasal outcome test (SNOT-22): a scoping review. Int Forum Allergy Rhinol 12(1):83–102. https://doi.org/10.1002/alr.22888

Article  PubMed  Google Scholar 

Meltzer EO, Hamilos DL, Hadley JA et al (2004) Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 114(6 Suppl):155–212. https://doi.org/10.1016/j.jaci.2004.09.029

Article  PubMed  PubMed Central  Google Scholar 

Psaltis AJ, Li G, Vaezeafshar R, Cho KS, Hwang PH (2014) Modification of the Lund-Kennedy endoscopic scoring system improves its reliability and correlation with patient-reported outcome measures. Laryngoscope 124(10):2216–2223. https://doi.org/10.1002/lary.24654

Article  PubMed  Google Scholar 

O’Brien WT Sr, Hamelin S, Weitzel EK (2016) The preoperative sinus CT: avoiding a “CLOSE” call with surgical complications. Radiology 281(1):10–21. https://doi.org/10.1148/radiol.2016152230

Article  PubMed  Google Scholar 

Maza-Solano JM, González-García J, Moreno-Luna R, Ambrosiani-Fernández J, Domínguez-Durán E, Sánchez-Gómez S (2018) “ABCDEF Checklist” based on 3D radiological images for preoperative planning of endoscopic sinus surgery. Rhinology Online 1:133–142. https://doi.org/10.4193/RHINOL/18.054

Article  Google Scholar 

Sedaghat AR, Kuan EC, Scadding GK (2022) Epidemiology of chronic rhinosinusitis: prevalence and risk factors. J Allergy Clin Immunol Pract 10(6):1395–1403. https://doi.org/10.1016/j.jaip.2022.01.016

Article  PubMed  Google Scholar 

Stevens WW, Peters AT, Tan BK et al (2019) Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract 7(8):2812-2820.e3. https://doi.org/10.1016/j.jaip.2019.05.009

Article  PubMed  PubMed Central  Google Scholar 

Matucci A, Nencini F, Maggiore G et al (2022) High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients. Clin Exp Allergy. https://doi.org/10.1111/cea.14153

Article  PubMed  Google Scholar 

Fokkens WJ, Lund V, Luong AU, Orlandi RR (2022) A comparison of international guidelines for rhinosinusitis. J Allergy Clin Immunol Pract 10(6):1418–1422. https://doi.org/10.1016/j.jaip.2022.01.013

Article  PubMed  Google Scholar 

Meirte J, Hellemans N, Anthonissen M et al (2020) Benefits and disadvantages of electronic patient-reported outcome measures: systematic review. JMIR Perioper Med 3(1):e15588. https://doi.org/10.2196/15588

Article  PubMed  PubMed Central  Google Scholar 

Robinson D, Humbert M, Buhl R et al (2017) Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy 47(2):161–175. https://doi.org/10.1111/cea.12880

Article  CAS  PubMed  Google Scholar 

Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP (2021) Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract 9(3):1133–1141. https://doi.org/10.1016/j.jaip.2020.09.063

Article  CAS  PubMed  Google Scholar 

De Corso E, Lucidi D, Battista M et al (2017) Prognostic value of nasal cytology and clinical factors in nasal polyps development in patients at risk: can the beginning predict the end? Int Forum Allergy Rhinol 7(9):861–867. https://doi.org/10.1002/alr.21979

Article  PubMed  Google Scholar 

Rimmer J, Hellings P, Lund VJ et al (2019) European position paper on diagnostic tools in rhinology. Rhinology 57(S28):1–41. https://doi.org/10.4193/Rhin19.410

Article  CAS  PubMed  Google Scholar 

Coates ML, Martinez Del Pero M (2020) Updates in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis for the ENT surgeon. Clin Otolaryngol 45(3):316–326. https://doi.org/10.1111/coa.13524

Article  PubMed  Google Scholar 

Yamazaki K, Nomizo T, Hatanaka K et al (2022) Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab. J Allergy Clin Immunol 1(3):180–182. https://doi.org/10.1016/j.jacig.2022.03.006

Article  Google Scholar 

Patel GB, Peters AT (2021) The role of biologics in chronic rhinosinusitis with nasal polyps. Ear Nose Throat J 100(1):44–47. https://doi.org/10.1177/0145561320964653

Article  PubMed  Google Scholar 

Hopkins C, Browne JP, Slack R et al (2006) The national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Clin Otolaryngol 31(5):390–398. https://doi.org/10.1111/j.1749-4486.2006.01275.x

Article  CAS  PubMed  Google Scholar 

Le PT, Soler ZM, Jones R, Mattos JL, Nguyen SA, Schlosser RJ (2018) Systematic review and meta-analysis of SNOT-22 outcomes after surgery for chronic rhinosinusitis with nasal polyposis. Otolaryngol Head Neck Surg 159(3):414–423. https://doi.org/10.1177/0194599818773065

Article  PubMed  Google Scholar 

Wu Q, Zhang Y, Kong W et al (2022) Which is the best biologic for nasal polyps: dupilumab, omalizumab, or mepolizumab? A network meta-analysis. Int Arch Allergy Immunol 183(3):279–288. https://doi.org/10.1159/000519228

Article  CAS  PubMed  Google Scholar 

Longino ES, Labby AB, Wu J et al (2022) Association of cytokine profile with prior treatment failure and revision surgery in chronic rhinosinusitis. Int Forum Allergy Rhinol. https://doi.org/10.1002/alr.23035

Article  PubMed  PubMed Central  Google Scholar 

Chapurin N, Li P, Chandra RK, Turner JH, Chowdhury NI (2021) Elevated mucus interleukin-17A levels are associated with increased prior sinus surgery for chronic rhinosinusitis. Int Forum Allergy Rhinol 11(2):120–127. https://doi.org/10.1002/alr.22652

Article  PubMed  Google Scholar 

Kim J, Naclerio R (2020) Therapeutic potential of dupilumab in the treatment of chronic rhinosinusitis with nasal polyps: evidence to date. Ther Clin Risk Manag 16:31–37. https://doi.org/10.2147/TCRM.S210648

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dharmarajan H, Falade O, Lee SE, Wang EW (2021) Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. https://doi.org/10.1002/alr.22951

Article  Google Scholar 

Scangas GA, Wu AW, Ting JY et al (2021) Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Laryngoscope 131(1):E26–E33. https://doi.org/10.1002/lary.28648

Article  CAS  PubMed  Google Scholar 

Cabana MD, Rand CS, Powe NR et al (1999) Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 282(15):1458–1465. https://doi.org/10.1001/jama.282.15.1458